2Stuck AE, Minder CE, Frey FJ. Risk of infectious complications in patients taking glucocorticoids. Rev Infect Dis 1989:11(6):954–63.

NOVAPLUS is a registered trademark of Novation, LLC.

Rx only

LAB-0408-3.0
October 2009

PRINCIPAL DISPLAY PANEL - 1 mL Vial Carton
NDC 0009-0039-32
Contains 25 of NDC 0009-0039-33

SOLU-MEDROL®
methylprednisolone sodium succinate for injection, USP

40 mg*

For intramuscular or intravenous use

Preservative-Free

Single-Dose Vials
25–1 mL Act-O-Vial® Systems
Rx ONLY

NOVAPLUS®

PRINCIPAL DISPLAY PANEL - 2 mL Vial Carton
NDC 0009-0047-26
Contains 25 of NDC 0009-0047-27

SOLU-MEDROL®
methylprednisolone sodium succinate for injection, USP

125 mg*

For intramuscular or intravenous use

Preservative-Free

Single-Dose Vials
25–2 mL Act-O-Vial® Systems
Rx ONLY

NOVAPLUS®

SOLU-MEDROL
methylprednisolone sodium succinate injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0009-0039
Route of Administration INTRAVENOUS,INTRAMUSCULAR DEA Schedule 
 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
methylprednisolone sodium succinate(methylprednisolone) methylprednisolone 40mg in1mL
 
Inactive Ingredients
Ingredient Name Strength
sodium phosphate, monobasic anhydrous 1.6mg in1mL
sodium phosphate, dibasic 17.46mg in1mL
lactose monohydrate 25mg in1mL
 
Product Characteristics
Color  Score 
Shape  Size 
Flavor  Imprint Code 
Contains 
 
Packaging
# NDC Package Description Multilevel Packaging
1 0009-0039-32 25VIALIn1PACKAGE contains a VIAL, PATENT DELIVERY SYSTEM
1  1mLIn1VIAL, PATENT DELIVERY SYSTEM This package is contained within the PACKAGE(0009-0039-32)
 

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA011856 04/02/1959 

SOLU-MEDROL
methylprednisolone sodium succinate injection, powder, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG NDC Product Code (Source) 0009-0047
Route of Administration INTRAVENOUS,INTRAMUSCULAR DEA Schedule 
 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
methylprednisolone sodium succinate(methylprednisolone) methylprednisolone 125mg in1mL
 
Inactive Ingredients
Ingredient Name Strength
sodium phosphate, monobasic anhydrous 1.6mg in1mL
sodium phosphate, dibasic 17.4mg in1mL
 
Product Characteristics
Color  Score 
Shape  Size 
Flavor  Imprint Code 
Contains 
 
Packaging
# NDC Package Description Multilevel Packaging
1 0009-0047-26 25VIALIn1PACKAGE contains a VIAL, PATENT DELIVERY SYSTEM
1  2mLIn1VIAL, PATENT DELIVERY SYSTEM This package is contained within the PACKAGE(0009-0047-26)
 

Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date